gliptin and glp-1 Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus Frontiers | Clinical Use of

The widely accepted GLP-1 movement is starting to break down barriers

Its extensive research history and robust dose-response data make it a well-characterized pharmacological tool

Anti-inflammation and Anti-oxidation: the Key to unlocking the Cardiovascular potential of SGLT2 inhibitors and GLP1 receptor agonists

GLP-1 Receptor Agonists Available Several GLP-1 medications are available, with important differences: Semaglutide (Ozempic for diabetes, Wegovy for weight loss) has become the most widely used due to its combination of efficacy, once-weekly dosing, and substantial clinical trial data

This helps increase your blood volume, which elevates blood pressure levels

It slows down gastric emptying, making you feel fuller for longer after meals, and reduces cravings